United States
Read insights from the PE community on managing portfolio company cash flow, assessing operational threats and planning the next M&A move.
The coronavirus outbreak has become a watershed moment for the private equity (PE) industry—and very quickly.
We are in the midst of a pandemic; RSM offers perspectives and insights on how COVID-19 has impacted M&A in the health care sector.
COVID-19 EBITDA analyses are imperative. A mutual understanding between a buyer and seller of the financial model assumptions is key
To identify risks and opportunities in telehealth deals, investors must assess these key IT and security considerations.